Structural and functional characterization of a monoclonal antibody blocking TIGIT

MG1141A as a highly potent monoclonal neutralizing antibody against SARS-CoV-2 variants

MG1113, a specific anti–tissue factor pathway inhibitor antibody, rebalances the coagulation system and promotes hemostasis in hemophilia

Abrogation of HLA surface expression using CRISPR/Cas9 genome editing: a step toward universal T cell therapy